Medical Technology Commercialization is a high-risk/high-return activity. Multiples for successful Medtech exits are higher than those for most other industries including iT. These high multiples are a reflection of the risks involved in the process. Failure rates in Medtech commercialization are high and can come from almost anywhere. Risks are multifaceted and include regulatory risk, clinical trial failure, competitive incursion, under-capitalization, failure to de-risk or properly scale prototype technologies, inability to attract talent or retain key talent as well as failure to properly secure IP.
Request your free white paper to learn more about the importance of;
- refining your product concept,
- the pivotol role of product positioning
- the power of achieving your critical 1st sale